Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Aug;89(2):165–169. doi: 10.1111/j.1365-2249.1992.tb06926.x

Experimental autoimmune uveoretinitis (EAU) versus experimental allergic encephalomyelitis (EAE): a comparison of T cell-mediated mechanisms.

V L Calder 1, S L Lightman 1
PMCID: PMC1554436  PMID: 1638760

Abstract

EAU is a model of ocular inflammatory disease. EAU resembles another T cell-mediated autoimmune disease--experimental allergic encephalomyelitis--since both have increased expression of MHC class II molecules in the target tissue, can be adoptively transferred by activated CD4+ T cells and are inhibited by cyclosporin A. The immunological findings will be compared to find out if the same cellular mechanisms are involved in both diseases.

Full text

PDF
165

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atalla L., Linker-Israeli M., Steinman L., Rao N. A. Inhibition of autoimmune uveitis by anti-CD4 antibody. Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1264–1270. [PubMed] [Google Scholar]
  2. Calder V. L., Wolswijk G., Noble M. The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. Eur J Immunol. 1988 Aug;18(8):1195–1201. doi: 10.1002/eji.1830180808. [DOI] [PubMed] [Google Scholar]
  3. Cannella B., Cross A. H., Raine C. S. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med. 1990 Nov 1;172(5):1521–1524. doi: 10.1084/jem.172.5.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caspi R. R., Kuwabara T., Nussenblatt R. B. Characterization of a suppressor cell line which downgrades experimental autoimmune uveoretinitis in the rat. J Immunol. 1988 Apr 15;140(8):2579–2584. [PubMed] [Google Scholar]
  5. Caspi R. R., Roberge F. G., Chan C. C., Wiggert B., Chader G. J., Rozenszajn L. A., Lando Z., Nussenblatt R. B. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol. 1988 Mar 1;140(5):1490–1495. [PubMed] [Google Scholar]
  6. Caspi R. R., Roberge F. G., McAllister C. G., el-Saied M., Kuwabara T., Gery I., Hanna E., Nussenblatt R. B. T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol. 1986 Feb 1;136(3):928–933. [PubMed] [Google Scholar]
  7. Chan C. C., Hooks J. J., Nussenblatt R. B., Detrick B. Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis. Curr Eye Res. 1986 Apr;5(4):325–330. doi: 10.3109/02713688609020059. [DOI] [PubMed] [Google Scholar]
  8. Chan C. C., Mochizuki M., Nussenblatt R. B., Palestine A. G., McAllister C., Gery I., BenEzra D. T-lymphocyte subsets in experimental autoimmune uveitis. Clin Immunol Immunopathol. 1985 Apr;35(1):103–110. doi: 10.1016/0090-1229(85)90083-2. [DOI] [PubMed] [Google Scholar]
  9. Chluba J., Steeg C., Becker A., Wekerle H., Epplen J. T. T cell receptor beta chain usage in myelin basic protein-specific rat T lymphocytes. Eur J Immunol. 1989 Feb;19(2):279–284. doi: 10.1002/eji.1830190210. [DOI] [PubMed] [Google Scholar]
  10. Clayton J. P., Gammon G. M., Ando D. G., Kono D. H., Hood L., Sercarz E. E. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med. 1989 May 1;169(5):1681–1691. doi: 10.1084/jem.169.5.1681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cousins S. W., McCabe M. M., Danielpour D., Streilein J. W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2201–2211. [PubMed] [Google Scholar]
  12. Craggs R. I., Webster H. D. Ia antigens in the normal rat nervous system and in lesions of experimental allergic encephalomyelitis. Acta Neuropathol. 1985;68(4):263–272. doi: 10.1007/BF00690828. [DOI] [PubMed] [Google Scholar]
  13. Fontana A., Fierz W., Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 1984 Jan 19;307(5948):273–276. doi: 10.1038/307273a0. [DOI] [PubMed] [Google Scholar]
  14. Forrester J. V., Liversidge J., Dua H. S., Towler H., McMenamin P. G. Comparison of clinical and experimental uveitis. Curr Eye Res. 1990;9 (Suppl):75–84. doi: 10.3109/02713689008999424. [DOI] [PubMed] [Google Scholar]
  15. Fox G. M., Kuwabara T., Wiggert B., Redmond T. M., Hess H. H., Chader G. J., Gery I. Experimental autoimmune uveoretinitis (EAU) induced by retinal interphotoreceptor retinoid-binding protein (IRBP): differences between EAU induced by IRBP and by S-antigen. Clin Immunol Immunopathol. 1987 May;43(2):256–264. doi: 10.1016/0090-1229(87)90133-4. [DOI] [PubMed] [Google Scholar]
  16. Fujikawa L. S., Chan C. C., McAllister C., Gery I., Hooks J. J., Detrick B., Nussenblatt R. B. Retinal vascular endothelium expresses fibronectin and class II histocompatibility complex antigens in experimental autoimmune uveitis. Cell Immunol. 1987 Apr 15;106(1):139–150. doi: 10.1016/0008-8749(87)90157-2. [DOI] [PubMed] [Google Scholar]
  17. Fujinami R. S., Oldstone M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985 Nov 29;230(4729):1043–1045. doi: 10.1126/science.2414848. [DOI] [PubMed] [Google Scholar]
  18. Fujino Y., Okumura A., Nussenblatt R. B., Gery I., Mochizuki M. Cyclosporine-induced specific unresponsiveness to retinal soluble antigen in experimental autoimmune uveoretinitis. Clin Immunol Immunopathol. 1988 Feb;46(2):234–248. doi: 10.1016/0090-1229(88)90186-9. [DOI] [PubMed] [Google Scholar]
  19. Hardcastle J. D., Farrands P. A., Balfour T. W., Chamberlain J., Amar S. S., Sheldon M. G. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet. 1983 Jul 2;2(8340):1–4. doi: 10.1016/s0140-6736(83)90001-6. [DOI] [PubMed] [Google Scholar]
  20. Hickey W. F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1991 Jan;1(2):97–105. doi: 10.1111/j.1750-3639.1991.tb00646.x. [DOI] [PubMed] [Google Scholar]
  21. Jacobs C. A., Baker P. E., Roux E. R., Picha K. S., Toivola B., Waugh S., Kennedy M. K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J Immunol. 1991 May 1;146(9):2983–2989. [PubMed] [Google Scholar]
  22. Johnson R. T., Griffin D. E., Hirsch R. L., Wolinsky J. S., Roedenbeck S., Lindo de Soriano I., Vaisberg A. Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med. 1984 Jan 19;310(3):137–141. doi: 10.1056/NEJM198401193100301. [DOI] [PubMed] [Google Scholar]
  23. Kawashima H., Fujino Y., Mochizuki M. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci. 1988 Aug;29(8):1265–1271. [PubMed] [Google Scholar]
  24. Kotake S., de Smet M. D., Wiggert B., Redmond T. M., Chader G. J., Gery I. Analysis of the pivotal residues of the immunodominant and highly uveitogenic determinant of interphotoreceptor retinoid-binding protein. J Immunol. 1991 May 1;146(9):2995–3001. [PubMed] [Google Scholar]
  25. Lamont A. G., Sette A., Fujinami R., Colón S. M., Miles C., Grey H. M. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules. J Immunol. 1990 Sep 15;145(6):1687–1693. [PubMed] [Google Scholar]
  26. Lider O., Reshef T., Beraud E., Ben-Nun A., Cohen I. R. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science. 1988 Jan 8;239(4836):181–183. doi: 10.1126/science.2447648. [DOI] [PubMed] [Google Scholar]
  27. Lider O., Santos L. M., Lee C. S., Higgins P. J., Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol. 1989 Feb 1;142(3):748–752. [PubMed] [Google Scholar]
  28. Lightman S. L., Caspi R. R., Nussenblatt R. B., Palestine A. G. Antigen-directed retention of an autoimmune T-cell line. Cell Immunol. 1987 Nov;110(1):28–34. doi: 10.1016/0008-8749(87)90098-0. [DOI] [PubMed] [Google Scholar]
  29. Liversidge J., Sewell H. F., Forrester J. V. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology. 1990 Nov;71(3):390–396. [PMC free article] [PubMed] [Google Scholar]
  30. Liversidge J., Thomson A. W., Sewell H. F., Forrester J. V. EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A. Clin Exp Immunol. 1987 Sep;69(3):591–600. [PMC free article] [PubMed] [Google Scholar]
  31. Male D., Pryce G. Induction of Ia molecules on brain endothelium is related to susceptibility to experimental allergic encephalomyelitis. J Neuroimmunol. 1989 Jan;21(1):87–90. doi: 10.1016/0165-5728(89)90163-x. [DOI] [PubMed] [Google Scholar]
  32. Male D., Pyrce G., Hughes C., Lantos P. Lymphocyte migration into brain modelled in vitro: control by lymphocyte activation, cytokines, and antigen. Cell Immunol. 1990 Apr 15;127(1):1–11. doi: 10.1016/0008-8749(90)90109-5. [DOI] [PubMed] [Google Scholar]
  33. Mochizuki M., Kuwabara T., McAllister C., Nussenblatt R. B., Gery I. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci. 1985 Jan;26(1):1–9. [PubMed] [Google Scholar]
  34. Naparstek Y., Ben-Nun A., Holoshitz J., Reshef T., Frenkel A., Rosenberg M., Cohen I. R. T lymphocyte lines producing or vaccinating against autoimmune encephalomyelitis (EAE). Functional activation induces peanut agglutinin receptors and accumulation in the brain and thymus of line cells. Eur J Immunol. 1983 May;13(5):418–423. doi: 10.1002/eji.1830130513. [DOI] [PubMed] [Google Scholar]
  35. Naparstek Y., Cohen I. R., Fuks Z., Vlodavsky I. Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature. 1984 Jul 19;310(5974):241–244. doi: 10.1038/310241a0. [DOI] [PubMed] [Google Scholar]
  36. Nussenblatt R. B., Caspi R. R., Mahdi R., Chan C. C., Roberge F., Lider O., Weiner H. L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol. 1990 Mar 1;144(5):1689–1695. [PubMed] [Google Scholar]
  37. PATERSON P. Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med. 1960 Jan 1;111:119–136. doi: 10.1084/jem.111.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Palestine A. G., Nussenblatt R. B., Chan C. C. Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. Am J Ophthalmol. 1985 Feb 15;99(2):210–211. doi: 10.1016/0002-9394(85)90237-5. [DOI] [PubMed] [Google Scholar]
  39. Racke M. K., Dhib-Jalbut S., Cannella B., Albert P. S., Raine C. S., McFarlin D. E. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol. 1991 May 1;146(9):3012–3017. [PubMed] [Google Scholar]
  40. Raine C. S., Barnett L. B., Brown A., Behar T., McFarlin D. E. Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest. 1980 Aug;43(2):150–157. [PubMed] [Google Scholar]
  41. Raine C. S. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest. 1984 Jun;50(6):608–635. [PubMed] [Google Scholar]
  42. Rudge P., Koetsier J. C., Mertin J., Mispelblom Beyer J. O., Van Walbeek H. K., Clifford Jones R., Harrison J., Robinson K., Mellein B., Poole T. Randomised double blind controlled trial of cyclosporin in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1989 May;52(5):559–565. doi: 10.1136/jnnp.52.5.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. STONE S. H., LERNER E. M., 2nd CHRONIC DISSEMINATED ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS. Ann N Y Acad Sci. 1965 Mar 31;122:227–241. doi: 10.1111/j.1749-6632.1965.tb20206.x. [DOI] [PubMed] [Google Scholar]
  44. Sedgwick J. D. Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur J Immunol. 1988 Apr;18(4):495–502. doi: 10.1002/eji.1830180402. [DOI] [PubMed] [Google Scholar]
  45. Singh V. K., Kalra H. K., Yamaki K., Abe T., Donoso L. A., Shinohara T. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J Immunol. 1990 Feb 15;144(4):1282–1287. [PubMed] [Google Scholar]
  46. Singh V. K., Nussenblatt R. B., Donoso L. A., Yamaki K., Chan C. C., Shinohara T. Identification of a uveitopathogenic and lymphocyte proliferation site in bovine S-antigen. Cell Immunol. 1988 Sep;115(2):413–419. doi: 10.1016/0008-8749(88)90193-1. [DOI] [PubMed] [Google Scholar]
  47. Singh V. K., Yamaki K., Donoso L. A., Shinohara T. Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis. J Immunol. 1989 Mar 1;142(5):1512–1517. [PubMed] [Google Scholar]
  48. Steinman L., Solomon D., Lim M., Zamvil S., Sriram S. Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous system. J Neuroimmunol. 1983 Aug;5(1):91–97. doi: 10.1016/0165-5728(83)90029-2. [DOI] [PubMed] [Google Scholar]
  49. Towler H. M., Cliffe A. M., Whiting P. H., Forrester J. V. Low dose cyclosporin A therapy in chronic posterior uveitis. Eye (Lond) 1989;3(Pt 3):282–287. doi: 10.1038/eye.1989.39. [DOI] [PubMed] [Google Scholar]
  50. Tuohy V. K., Lu Z., Sobel R. A., Laursen R. A., Lees M. B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol. 1989 Mar 1;142(5):1523–1527. [PubMed] [Google Scholar]
  51. Vandenbark A. A., Hashim G. A., Celnik B., Galang A., Li X. B., Heber-Katz E., Offner H. Determinants of human myelin basic protein that induce encephalitogenic T cells in Lewis rats. J Immunol. 1989 Dec 1;143(11):3512–3516. [PubMed] [Google Scholar]
  52. Vandenbark A. A., Hashim G., Offner H. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature. 1989 Oct 12;341(6242):541–544. doi: 10.1038/341541a0. [DOI] [PubMed] [Google Scholar]
  53. Vandenbark A. A., Offner H., Reshef T., Fritz R., Chou C. H., Cohen I. R. Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol. 1985 Jul;135(1):229–233. [PubMed] [Google Scholar]
  54. Wacker W. B., Donoso L. A., Kalsow C. M., Yankeelov J. A., Jr, Organisciak D. T. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol. 1977 Dec;119(6):1949–1958. [PubMed] [Google Scholar]
  55. Waldor M. K., Sriram S., Hardy R., Herzenberg L. A., Herzenberg L. A., Lanier L., Lim M., Steinman L. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science. 1985 Jan 25;227(4685):415–417. doi: 10.1126/science.3155574. [DOI] [PubMed] [Google Scholar]
  56. Watanabe R., Wege H., ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature. 1983 Sep 8;305(5930):150–153. doi: 10.1038/305150a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Wetzig R., Hooks J. J., Percopo C. M., Nussenblatt R., Chan C. C., Detrick B. Anti-Ia antibody diminishes ocular inflammation in experimental autoimmune uveitis. Curr Eye Res. 1988 Aug;7(8):809–818. doi: 10.3109/02713688809033212. [DOI] [PubMed] [Google Scholar]
  58. Williams R. M., Moore M. J. Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med. 1973 Oct 1;138(4):775–783. doi: 10.1084/jem.138.4.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Wiśniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann Neurol. 1977 Feb;1(2):144–148. doi: 10.1002/ana.410010207. [DOI] [PubMed] [Google Scholar]
  60. Woodroofe M. N., Hayes G. M., Cuzner M. L. Fc receptor density, MHC antigen expression and superoxide production are increased in interferon-gamma-treated microglia isolated from adult rat brain. Immunology. 1989 Nov;68(3):421–426. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES